New combo therapy hopes to tame advanced cancers
NCT ID NCT06771622
First seen Feb 04, 2026 · Last updated Apr 30, 2026 · Updated 12 times
Summary
This study tests a new drug called HCB101 combined with standard cancer treatments for people with advanced solid tumors that have not responded well to prior therapy. The goal is to find the safest dose and see if the combination can shrink tumors. About 500 adults with various cancers like stomach, colorectal, or breast cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, China
Conditions
Explore the condition pages connected to this study.